Ausgabe 1/2024
Inhalt (6 Artikel)
Effect of Levetiracetam on Cognition: A Systematic Review and Meta-analysis of Double-Blind Randomized Placebo-Controlled Trials
Chia-Yen Lin, Meng-Chia Chang, Hong-Jie Jhou
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future
Salvatore Crisafulli, Brigida Boccanegra, Massimo Carollo, Emanuela Bottani, Paola Mantuano, Gianluca Trifirò, Annamaria De Luca
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
Chuanjun Zhuo, Qiuyu Zhang, Lina Wang, Xiaoyan Ma, Ranli Li, Jing Ping, Jingjing Zhu, Hongjun Tian, Deguo Jiang
Treatment of Sleep, Motor and Sensory Symptoms with the Orexin Antagonist Suvorexant in Adults with Idiopathic Restless Legs Syndrome: A Randomized Double-Blind Crossover Proof-of-Concept Study
Diego Garcia-Borreguero, Alba Garcia Aragón, Brian Moncada, Sofia Romero, Juan José Granizo, Sonia Quintas, María Castillo
Factors Associated with Symptom Stabilization that Allow for Successful Transition from Once-Monthly Paliperidone Palmitate to Three-Monthly Paliperidone Palmitate: A Post Hoc Analysis Examined Clinical Characteristics in Chinese Patients with Schizophrenia
Xin Li, Chong Ye, Wanyi Zhang, Miaomiao Jia, Gang Wang
Thrombolysis with Recombinant Human Prourokinase 4.5–6 h After Acute Ischemic Stroke: A Phase IIa, Randomized, and Open-Label Multicenter Clinical Trial
Haiqing Song, Yuan Wang, Qingfeng Ma, Huisheng Chen, Bo Liu, Yi Yang, Jianguo Zhu, Shigang Zhao, Xiaoping Jin, Yongqiu Li, Yanyong Wang, Runxiu Zhu, Liandong Zhao, Junyan Liu, Wuwei Feng, Rui Liu, Xunming Ji, Yuping Wang